Evaluation of drug formulations using LD50 testing in mice

Area of Science:

• Pharmacology
• Drug Delivery Systems
• Toxicology

Background:

• Assessing the absorption of poorly soluble drugs is critical for effective therapeutic outcomes.
• Developing advanced drug formulations can significantly improve bioavailability.
• Standardized methods are needed for comparative evaluation of these formulations.

Purpose of the Study:

• To utilize LD50 values to assess the relative absorption rates of two poorly soluble drugs.
• To compare the toxicities of various formulations against pure drugs.
• To demonstrate the practicality and rapidity of the LD50 method for formulation evaluation.

Main Methods:

• Studied drug formulations using techniques such as micronization, surfactant addition, coprecipitation, and granulation.
• Administered various formulations and pure drugs to determine LD50 values.
• Employed alkaline or buffering agents and bile salts in formulation development.

Main Results:

• Demonstrated differences in toxicity between drug formulations and pure drugs using the LD50 method.
• Successfully utilized LD50 values to compare the relative absorption rates of poorly soluble drugs.
• Confirmed the effectiveness of various formulation strategies in altering drug absorption and toxicity.

Conclusions:

• The LD50 method is a practical and rapid approach for comparative evaluation of drug formulations.
• Formulation strategies significantly impact the absorption and toxicity profiles of poorly soluble drugs.
• LD50 assessment offers valuable insights into drug bioavailability and formulation efficacy.